Regeneron Pharmaceuticals, Inc.

NasdaqGS:REGN Stock Report

Mkt Cap: US$85.6b

Regeneron Pharmaceuticals Financial Health

How is Regeneron Pharmaceuticals's financial position?

Financial Health Score

0/6

Financial Health Score 0/6

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies